GenSight Biologics logo

GenSight Biologics

ID: 5637508

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

9

Funding Rounds

$231.7m

Money raised

Overview

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding series

Funding Series Analysis

The company GenSight Biologics has raised a total of $41.67m in funding over 9 rounds.

Key Insights:

  • GenSight Biologics Series A round: $41.67m
  • GenSight Biologics Series B round, July 2015: $36m
  • GenSight Biologics Series A round, April 2013: $38.42m
  • GenSight Biologics Venture round, June 2017: $27.02m
  • GenSight Biologics Venture round, February 2019: $9.61m
  • GenSight Biologics Venture round, December 2019: $18.01m
  • GenSight Biologics Venture round, October 2020: $25m
  • GenSight Biologics Venture round, March 2021: $36.02m